Hovorka 2000.

Study characteristics
Methods	A single‐centre, non‐randomised, uncontrolled, prospective before and after study (Prague) Baseline period: 2 months Treatment period: 8 weeks
Participants	43 people with focal epilepsy exceeding 15 points on the Hamilton Rating Scale for Depression (HAMD) 21 scale for depression 35 females and 8 males Aged 21 to 49 years: mean 33.2 years
Interventions	Citalopram at a flexible dose; the average dose was 19.3 mg ± 2.6 mg at the end of the first month, 22.62 mg ± 8.3 mg at the end of the second month
Outcomes	1) Seizure frequency 2) Depressive symptoms measured by the HAMD‐21 3) Adverse effects
Notes	No dropouts and no exclusions from the analysis